About
Our Mission
Leadership
Partners
Our Technologies
TALEN® Technology
Gene Editing
PulseAgile Technology
Patents
Pipeline
Products
Clinical Indications
Manufacturing
Investors
Press Releases
Corporate presentation & ESG report
Scientific Presentations
Scientific Publications
Events and Webcasts
2021 Cellectis Innovation Days
Stock Information
Corporate Governance
Governance Documents
Board of Directors & Committee Members
Shareholders Meeting
SEC Filings
Contact
IR Inquiries
Email Alerts
Investor FAQ
Careers
Our Culture
Job Opportunities
Contact us
fr
Press Releases
Our latest news and press releases
Press releases
Corporate presentation
Scientific Presentations
Scientific Publications
Events and webcasts
Stock information
SEC filings
Financial Statements
Regulated information
Voting Rights & Share Capital
ATM Program
General meetings
Governance
The board and committee members
Corporate governance documents
FAQ
IR Inquiry
All
2024
2023
2022
2021
2020
11
May 2020
16:30 E.S.T.
Cellectis’ Annual Shareholders’ General Meeting to be Held on June 29, 2020
Read more
06
May 2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020
Read more
29
Apr 2020
16:30 E.S.T.
Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT
Read more
13
Apr 2020
16:30 E.S.T.
Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer
Read more
10
Mar 2020
16:30 E.S.T.
US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis
Read more
04
Mar 2020
16:30 E.S.T.
Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results
Read more
Prev
2
3
4
5
Next